Mylan Inc

The company was accused of overcharging the government for EpiPens.
Refined coal has quietly generated hundreds of millions of dollars of tax credits for the company over the last six years.
The amount is nearly three times a proposed settlement that the company announced in October.
Violations included a failure to “thoroughly investigate” unexplained discrepancies in drug batches and “missing, deleted, and lost data."
The company came under fire last year after prices for its allergy devices shot up.